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Abstract Öz 
Cutaneous allergic reactions due to drug intake may be 
triggered by many types of drugs such as atropine, 
anticonvulsants and benzodiazepines. But allergic 
reactions due to benzodiazepines are extremely rare. 
Alprazolam is a benzodiazepine which may be useful for 
refractory idiopathic urticaria due to antihistaminergic 
effect. Although antihistaminergic effect of alprazolam, a 
cold urticaria case and an angioedema case induced by 
alprazolam are known in the literature. In the case, we 
present a child suffering from cutaneous allergic reaction 
due to alprazolam at the first dose taken. 
İlaca bağlı kutanöz alerjik reaksiyonlar atropin, 
antikonvulzanlar ve benzopiyazepinler gibi birçok ilaç türü 
ile ortaya çıkabilir. Fakat benzodiyazepinlere bağlı alerjik 
reaksiyonlar oldukça nadirdir. Alprazolam 
antihistaminerjik etkisinden dolayı refraktör idiyopatik 
ürtiker tedavisinde faydalı olabilecek bir bezodiyazepindir. 
Alprazolamın antihistaminerjik etkisine ragmen literatürde 
alprazolam ile tetiklenen bir anjioödem vakası ve bir de 
soğuk ürtikeri vakası bilinmektedir. Bu olguda tek doz 
alprazolamdan dolayı kutanöz alerjik reaksiyon gelişen bir 
çocuk sunulmuştur.  
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INTRODUCTION 
Drug reactions are frequently seen and the incidence 
of drug reactions is between 1-8 % in normal 
population. Of note, this proportion was reported 
to increase for non-steroid anti-inflammatory drugs, 
antibiotics and antiepileptic drugs1. Most of the drug 
reactions seen are cutaneous adverse effects2-4. 
Cutaneous reactions can be described as any 
undesired structural or functional changes in the 
skin, adnexa or mucous membranes caused by 
drugs5. Cutaneous reactions due to drug intake may 
be triggered by acetaminophen, antacids, atropine 
and benzodiazepines6-7.  
The data regarding the frequency of drug reactions 
in children is limited; it has been reported as 9.5% in 
the children in pediatrics clinics while it's 1.5% on 
polyclinic patient8. Moreover, it has been 
demonstrated that 39% of drug reactions seen in 
children can be life-threatening9. The drug reactions 
in children are frequently caused by antibiotics 
(penicillins, semi-synthetic penicillins, 
cephalosporins, trimethoprim-sulphomethoxazole) 
and anticonvulsants9. These are usually like 
exanthema, but they can be also urticarial, 
maculopapular (morbiliform), scarlatiniform, bullous 
or pustuler9. 
Allergic reactions due to benzodiazepines are 
extremely rare, and most have been associated with 
diazepam10. In the last decade, allergic reaction 
associated with alprazolam usage has not been 
reported except for an angioedema case and a cold 
urticaria case11,12. We hereby present a child 
suffering from cutaneous allergic reaction due to 
alprazolam at the first dose taken and also suffering 
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from moderate mental retardation with attention 
deficit-hyperactivity disorder (ADHD). 
CASE 
The case was admitted to our child and adolescent 
psychiatry out-patient clinic for the first time at the 
age of 10. He was born at 30 weeks of gestation by 
cesarean section. At the birth history, he suffered 
some asphyxiation, and his developmental skills 
were delayed relative to chronological age 
expectations. He could hear, but he could not speak 
any word.  
He maintained eye contact, understood commands 
and displayed facial mannerisms. But, he also had 
poor communication with his sibling and peers 
beyond that expected by his mutism. He displayed 
nocturnal and diurnal enuresis, hyperactivity, 
screaming, biting, injuring and hitting himself and 
other people in addition to chronic significant sleep 
disturbances. 
He had Moderate Mental Retardation according to 
DSM IV TR criteria. He could have attended only 
special education for five years. Initially, he was 
consulted to the pediatric urology department for 
the day and night wetting. His plain abdominal X-
ray graphy, abdominopelvic ultrasound, hemogram, 
liver function enzymes, total protein, B12, Folic 
acid, T3, T4, TSH , complete urine analysis and 
urine culture  results were normal. After all these 
detailed investigations, the pediatric urologist 
prescribed 1mg/day Tolterodin L-tartarat for the 
day and night wetting. 
We evaluated the case after the child urology 
department’s evaluation. He had harmful behaviors 
such as hitting, screaming. Furthermore, he had 
hyperactivity and sleep disturbance. He was 
diagnosed as Moderate Mental Retardation with 
ADHD according to DSM-IV criteria. We advised 
his mother to organize some social activities for him 
and we prescribed 0,5 mg/day risperidone for his 
disruptive behaviors. After 2 months, he came to 
our child and adolescent psychiatry outpatient clinic 
for a routine control. His behaviors got worse and 
his attachment to his mother was intensified. 
Additionally, his hyperactivity and irritability 
increased substantially. His symmetry and repeating 
compulsions began suddenly. We thought that 
akathisia developed due to risperidone, risperidone 
treatment stopped and 100 mg/day chlorpromazine 
was prescribed. 
After one month, his harmful behaviors decreased 
due to taking chlorpromazine treatment, but his 
sleep disturbance and irritability still continued.  
Therefore, alprazolam 0.5 mg/day was added to 
chlorpromazine treatment for sleep disturbance and 
irritability. 
Nearly twelve hours after adding alprazolam to the 
treatment, the patient developed generalized pruritic 
erythematous lesions especially localized on his face 
and dorsal parts of his hands. There was no 
mucosal, palmar or plantar involvement. He had no 
wheezing, dyspnea or intense cough. The 
dermatology department consulted the patient on 
the same day. An allergic drug reaction was 
presumed to be the cause and cetirizine 
hydrochloride was prescribed 10 mg BID. All skin 
lesions disappeared and cetirizine hydrochloride was 
quited in one week. Hydroxyzine hydrochloride 25 
mg/day was initiated for sleep problems. 
He is still being under follow-up in our child and 
adolescent outpatient clinic and he is using 
chlorpromazine 100 mg/day, hydroxyzine 
hydrochloride 25 mg/day, Tolterodin L-tartarat 1 
mg/day and his symptoms have lessened. 
DISCUSSION 
Although alprazolam is used widely in child and 
adolescent psychiatry clinics13, allergic skin reactions 
depending on alprazolam are rarely seen. As far as 
we know, allergic reaction due to alprazolam in 
treatment dosage has not been reported in the last 
decade except for an angioedema case and a cold 
urticaria case11,12.  
Twelve severe refractory idiopathic urticarial cases 
were divided to two groups: one of them is 
alprazolam taken, and the other is rupatidine taken. 
All of alprazolam group treated whereas the 2 
patients treated with rupatadine did not. Therefore, 
alprazolam may be an important agent on successful 
treatment of chronic drug- resistant urticaria14. 
Alprazolam has histamin H1 and H2 receptor 
antagonism in addition to increasing GABA 
receptor activity. This antihistaminergic effect is 
known to be responsible for successful treatment of 
drug resistant urticaria. Our case had mild allergic 
cutaneous reaction and no systemic complaints due 
to alprazolam allergy. Although antihistaminergic 
effect of alprazolam, allergic skin reaction is a rare 
clinical entity but may be encountered. On the other 
hand, severe conditions like angioedema could also 
 401 
Kütük et al.       Cukurova Medical Journal  
 
be seen, so clinicians should be aware of these rare 
complications of alprazolam treatment. 
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